UCSF to Coordinate Health Disparities Research in Multiple Chronic Diseases with $22.5M Grant

Tracking and integrating findings across disciplines is a persistent challenge in health disparities research. UC San Francisco faculty will soon take this challenge on with a new center to coordinate research from 11 newly funded centers across the U.S. on the root causes of, and ways to eliminate

Treating Anal Cancer Precursor Lesions Reduces Cancer Risk for People With HIV

Treating precursor anal cancer lesions can significantly reduce the risk of progression to full blown anal cancer among people living with HIV, according to results of a large, phase 3 study led by researchers at UC San Francisco. In a randomized clinical trial with 4,446 participants, known as the

Driving Dialogue and Discovery: Cancer Center Friday Seminar Series Enters Third Decade

Newly Approved Prostate Cancer Scan Can Detect Cells that Have Spread to Lymph Nodes

A revolutionary new diagnostic method for prostate cancer can detect prostate cancer cells that have spread to lymph nodes both inside and outside the pelvis, according to the UC San Francisco and UCLA team whose earlier work led to the test’s FDA approval. The test, which is now available at UCSF

Looking Beyond DNA to See Cancer with New Clarity

Researchers at UC San Francisco and UC San Diego have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease. The work points the way to identifying new precision treatments that may avoid the side effects

UCSF and Northwestern Awarded $4.2M to Advance Glioblastoma Therapeutics

Glioblastoma is the most common malignant brain tumor and among the most treatment-resistant cancers. In the last 15 years, numerous attempts to develop new drugs for glioblastoma have failed. In response, the National Cancer Institute (NCI) has established the Glioblastoma Therapeutics Network (GTN

An Estrogen Receptor that Promotes Cancer also Causes Drug Resistance

Cancer cells proliferate despite a myriad of stresses – from oxygen deprivation to chemotherapy – that would kill any ordinary cell. Now, researchers at UC San Francisco have gained insight into how they may be doing this through the downstream activity of a powerful estrogen receptor. The discovery